Praelia Pharmaceuticals, Vestiq’s supportive care company, will carry out the marketing and distribution activities of the product.
Formulated with 84mg of elemental magnesium L-lactate dehydrate in each MagBID ER caplet, four 84mg Mag-Tab SR caplets contain 336mg of magnesium meeting the USRDA range for the average adult female and male.
Praelia Pharmaceuticals president Steve Lutz said, "Because magnesium products’ solubility, absorption, and bioavailability affect patient response, it would likely require patients to take significantly more tablets of other magnesium products to provide the same amount of bioavailable magnesium as with each tablet of MagBID ER."
Low serum magnesium levels are believed to be associated with serious adverse events such as muscle spasm (tetany), irregular heartbeat (arrhythmias), and convulsions (seizures), according to the FDA.